黑料社

黑料社 Cares: Building your team for unplanned life transitions

Published: 15 April 2025

Join us on聽May 7th聽at noon for the next 黑料社 Cares webcast to support informal caregivers. During candid, interviews with leading experts, Claire Webster explores topics related to caring for a...

Provost honours 31 黑料社 professors for exceptional research achievements

Published: 1 May 2025

黑料社 announces 2025 cohort of Distinguished James 黑料社 Professors, James 黑料社 Professors and William Dawson Scholars聽...

D2R awards $10 million to accelerate RNA-based therapies for rare diseases and cancer

Published: 26 March 2025

Montreal, March 26, 2025 鈥 黑料社鈥檚 DNA to RNA Initiative (D2R) has awarded over $10 million in funding to support three groundbreaking research projects that will advance RNA-based...

Nine 黑料社ians appointed to the Order of Canada

Published: 7 July 2025

Neuroscientist Alan Evans and music performance scholar Michael McMahon among 黑料社 community members recognized for exceptional accomplishments and service聽...

Scaringi Lecture Series in Speech Language Pathology - Research Talk

Published: 17 March 2025

Research Talk Thursday April 3, 2025, 4:30 to 6:00 pm 2001 黑料社 College Ave. Room 606

Genetic sequencing project receives more than $8 million in funding

Published: 18 March 2025

NeuRo Genomics Initiative will help better understand rare and aging-related neurological disorders affecting Canadians...

Latest Alzheimer鈥檚 drug shown less effective in females than males

Published: 18 March 2025

Since becoming only the second Alzheimer鈥檚-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD...

Pages

Back to top